Latest News & Features
Europe
The Court of Appeal has overturned a ruling that revoked the pharma company’s cholesterol-lowering antibody patent, clarifying key principles for assessing inventive step. 27 November 2025
Americas
Director Squires rescinds previous guidelines and clarifies that there is no separate, modified inventorship standard for AI-assisted inventions. 27 November 2025
Europe
Even when legal teams do include women, the judges say they don’t always see or hear them, emphasising that visibility is critical for aspiring advocates. 27 November 2025
Big Pharma
Clinical trials create a patent paradox. With EPO case law rapidly reshaping the 'expectation of success' test—most recently T136/24—the line between innovation and obviousness is blurred. Amanda Simons of J A Kemp offers drafting strategies to secure protection for your downstream innovations. 27 November 2025
Americas
Balancing tight budgets while keeping up with fast-changing biosimilar rules is all in a day’s work for Novartis’s R&D IP team, but how do they stay on top of it all? 26 November 2025
Europe
Regeneron and Bayer suffered a UK setback as the court followed others in Europe in its interpretation of the so-called SPC manufacturing waiver. 25 November 2025
Careers
A regulatory counsel with nine years at the FDA and over two decades of patent experience has joined a firm in Washington, DC. 24 November 2025
Europe
Clients sending “masses of AI content” to patent attorneys is a growing problem, says the man leading the UK association’s AI Committee. Sarah Speight reports. 24 November 2025
Americas
The USPTO’s ‘settled expectations’ rule is anything but settled, argues Andrew Zappia of Troutman Pepper Locke. 24 November 2025
Europe
The week exposed fractures in the UK's industry—but also unexpected reasons for optimism. Five themes dominated conversations about the direction of the country's life sciences sector. 21 November 2025